In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 28, Issue 8, 2004, Pages 1313-1322

  Frederick, Blaise D ^a   Lyoo, In Kyoon ^a,c   Satlin, Andrew ^a,b   Ahn, Kyung Heup ^a   Kim, Minue J ^a   Yurgelun Todd, Deborah A ^a   Cohen, Bruce M ^a   Renshaw, Perry F ^a  

^a MCLEAN HOSPITAL   (United States)

^b MA USA   (United States)

^c Seoul National University Hospital   (South Korea)

Author keywords

Alzheimer's disease; Magnetic resonance spectroscopy; n acetyl aspartate; Temporal lobe

Indexed keywords

CREATINE; N ACETYLASPARTIC ACID;

AGED; ALZHEIMER DISEASE; AMNESIA; ARTICLE; BIPOLAR DISORDER; BRAIN LEVEL; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; HUMAN; IN VIVO STUDY; KORSAKOFF PSYCHOSIS; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; PARKINSON DISEASE; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPORAL LOBE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ASPARTIC ACID; BRAIN MAPPING; CASE-CONTROL STUDIES; CHOLINE; COGNITION DISORDERS; CREATINE; DEMENTIA; FEMALE; HUMANS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MEMORY DISORDERS; MENTAL STATUS SCHEDULE; PROTONS; TEMPORAL LOBE;

EID: 9944222544     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2004.08.013     Document Type: Article

References (45)

1. M. Barany, Y.C. Chang, C. Arus, T. Rustan, and W.H. Frey Increased glycerol-3-phosphorylcholine in post-mortem Alzheimer's brain Lancet 1 1985 517
2. P.B. Barker, B.J. Soher, S.J. Blackband, J.C. Chatham, V.P. Mathews, and R.N. Bryan Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference NMR Biomed. 6 1993 89 94
3. P.B. Barker, J.H. Gillard, P.C. van Zijl, B.J. Soher, D.F. Hanley, A.M. Agildere, S.M. Oppenheimer, and R.N. Bryan Acute stroke: evaluation with serial proton MR spectroscopic imaging Radiology 192 1994 723 732
4. J.A. Besson, P.V. Best, and E.R. Skinner Post-mortem proton magnetic resonance spectrometric measures of brain regions in patients with a pathological diagnosis of Alzheimer's disease and multi-infarct dementia Br. J. Psychiatry 160 1992 187 190
5. W. Block, F. Jessen, F. Traber, S. Flacke, C. Manka, R. Lamerichs, E. Keller, R. Heun, and H. Schild Regional N-acetyl aspartate reduction in the hippocampus detected with fast proton magnetic resonance spectroscopic imaging in patients with Alzheimer disease Arch. Neurol. 59 2002 828 834
6. W. Bondareff, J. Raval, P.M. Colletti, and D.L. Hauser Quantitative magnetic resonance imaging and the severity of dementia in Alzheimer's disease Am. J. Psychiatry 145 1988 853 856
7. H. Braak, E. Braak, and J. Bohl Staging of Alzheimer-related cortical destruction Eur. Neurol. 33 1993 403 408
8. J.C. Brooks, N. Roberts, G.J. Kemp, M.A. Gosney, M. Lye, and G.H. Whitehouse A proton magnetic resonance spectroscopy study of age-related changes in frontal lobe metabolite concentrations Cereb. Cortex 11 2001 598 605
9. A.A. Capizzano, N. Schuff, D.L. Amend, J.L. Tanabe, D. Norman, A.A. Maudsley, W. Jagust, H.C. Chui, G. Fein, M.R. Segal, and M.W. Weiner Subcortical ischemic vascular dementia: assessment with quantitative MR imaging and 1H MR spectroscopy Am. J. Neuroradiol. 21 2000 621 630
10. P. Christiansen, A. Schlosser, and O. Henriksen Reduced N-acetyl aspartate content in the frontal part of the brain in patients with probable Alzheimer's disease Magn. Reson. Imaging 13 1995 457 462
11. R. de Beer, A. van den Boogaart, D. van Ormondt, W.W. Pijnappel, J.A. den Hollander, A.J. Marien, and P.R. Luyten Application of time-domain fitting in the quantification of in vivo 1H spectroscopic imaging data sets NMR Biomed. 5 1992 171 178
12. P.M. Doraiswamy, H.C. Charles, and K.R. Krishnan Prediction of cognitive decline in early Alzheimer's disease Lancet 352 1998 1678
13. T. Ernst, L. Chang, R. Melchor, and C.M. Mehringer Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy Radiology 203 1997 829 836
14. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J. Psychiatr. Res. 12 1975 189 198
15. B.B. Frederick, A. Satlin, D.A. Yurgelun-Todd, and P.F. Renshaw In vivo proton magnetic resonance spectroscopy of Alzheimer's disease in the parietal and temporal lobes Biol. Psychiatry 42 1997 147 150
16. H. Fukuzako, T. Hashiguchi, Y. Sakamoto, H. Okamura, W. Doi, K. Takenouchi, and M. Takigawa Metabolite changes with age measured by proton magnetic resonance spectroscopy in normal subjects Psychiatry Clin. Neurosci. 51 1997 261 263
17. D.W. Hosmer, and S. Lemeshow Model-building strategies and methods for logistic regression Applied Logistic Regression 1989 John Wiley and Sons New York 82 134
18. W. Huang, G.E. Alexander, L. Chang, H.U. Shetty, J.S. Krasuski, S.I. Rapoport, and M.B. Schapiro Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study Neurology 57 2001 626 632
19. K.A. Jobst, A.D. Smith, M. Szatmari, A. Molyneux, M.E. Esiri, E. King, A. Smith, A. Jaskowski, B. McDonald, and N. Wald Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography Lancet 340 1992 1179 1183
20. K.A. Jobst, A.D. Smith, M. Szatmari, M.M. Esiri, A. Jaskowski, N. Hindley, B. McDonald, and A.J. Molyneux Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease Lancet 343 1994 829 830
21. K. Kantarci, C.R. Jack Jr., Y.C. Xu, N.G. Campeau, P.C. O'Brien, G.E. Smith, R.J. Ivnik, B.F. Boeve, E. Kokmen, E.G. Tangalos, and R.C. Petersen Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: a 1H MRS study Neurology 55 2000 210 217
22. R. Kikinis, M.E. Shenton, G. Gerig, J. Martin, M. Anderson, D. Metcalf, C.R. Guttmann, R.W. McCarley, W. Lorensen, and H. Cline Routine quantitative analysis of brain and cerebrospinal fluid spaces with MR imaging J. Magn. Reson. Imaging 2 1992 619 629
23. S.J. Kirsch, R.W. Jacobs, L.L. Butcher, and J. Beatty Prolongation of magnetic resonance T2 time in hippocampus of human patients marks the presence and severity of Alzheimer's disease Neurosci. Lett. 134 1992 187 190
24. W.E. Klunk, K. Panchalingam, J. Moossy, R.J. McClure, and J.W. Pettegrew N-acetyl-l-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study Neurology 42 1992 1578 1585
25. R. Kreis, T. Ernst, and B.D. Ross Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy Magn. Reson. Med. 30 1993 424 437
26. P.F. Kwo-On-Yuen, R.D. Newmark, T.F. Budinger, J.A. Kaye, M.J. Ball, and W.J. Jagust Brain N-acetyl-l-aspartic acid in Alzheimer's disease: a proton magnetic resonance spectroscopy study Brain Res. 667 1994 167 174
27. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944
28. T. Michaelis, K.D. Merboldt, H. Bruhn, W. Hanicke, and J. Frahm Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra Radiology 187 1993 219 227
29. R. Mielke, H.H. Schopphoff, H. Kugel, U. Pietrzyk, W. Heindel, J. Kessler, and W.D. Heiss Relation between 1H MR spectroscopic imaging and regional cerebral glucose metabolism in Alzheimer's disease Int. J. Neurosci. 107 2001 233 245
30. B.L. Miller, L. Chang, R. Booth, U. Pietrzyk, W. Heindel, J. Kessler, and W.D. Heiss In vivo 1H MRS choline: correlation with in vitro chemistry/histology Life Sci. 58 1996 1929 1935
31. R.A. Moats, T. Ernst, T.K. Shonk, and B.D. Ross Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease Magn. Reson. Med. 32 1994 110 115
32. C.M. Moore, B.B. Frederick, and P.F. Renshaw Brain biochemistry using magnetic resonance spectroscopy: relevance to psychiatric illness in the elderly J. Geriatr. Psychiatry Neurol. 12 1999 107 117
33. J.C. Morris, A. Heyman, R.C. Mohs, J.P. Hughes, G. van Belle, G. Fillenbaum, E.D. Mellits, and C. Clark The consortium to establish a registry for Alzheimer's disease (CERAD): Part I. Clinical and neuropsychological assessment of Alzheimer's disease Neurology 39 1989 1159 1165
34. L. Parnetti, R. Tarducci, O. Presciutti, D.T. Lowenthal, M. Pippi, B. Palumbo, G. Gobbi, G.P. Pelliccioli, and U. Senin Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging Mech. Ageing Dev. 97 1997 9 14
35. A. Pfefferbaum, E. Adalsteinsson, D. Spielman, E.V. Sullivan, and K.O. Lim In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease Arch. Gen. Psychiatry 56 1999 185 192
36. A. Shiino, M. Matsuda, S. Morikawa, T. Inubushi, I. Akiguchi, and J. Handa Proton magnetic resonance spectroscopy with dementia Surg. Neurol. 39 1993 143 147
37. T.K. Shonk, R.A. Moats, P. Gifford, T. Michaelis, J.C. Mandigo, J. Izumi, and B.D. Ross Probable Alzheimer disease: diagnosis with proton MR spectroscopy Radiology 195 1995 65 72
38. M.L. Simmons, C.G. Frondoza, and J.T. Coyle Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies Neuroscience 45 1991 37 45
39. Stata Stata 6.0 1999 Stata College Station, TX
40. D.S. Steffens MRI and MRS in dementia K.R. Krishnan P.M. Doraiswamy Brain Imaging in Clinical Psychiatry 1997 Marcel Dekker New York 503 533
41. J.C. Stout, T.L. Jernigan, S.L. Archibald, and D.P. Salmon Association of dementia severity with cortical gray matter and abnormal white matter volumes in dementia of the Alzheimer type Arch. Neurol. 53 1996 742 749
42. S. Takahashi, H. Yonezawa, J. Takahashi, M. Kudo, T. Inoue, and H. Tohgi Selective reduction of diffusion anisotropy in white matter of Alzheimer disease brains measured by 3.0 Tesla magnetic resonance imaging Neurosci. Lett. 332 2002 45 48
43. G. Tedeschi, A. Bertolino, N. Lundbom, S. Bonavita, N.J. Patronas, J.H. Duyn, L.V. Metman, T.N. Chase, and G. Di Chiro Cortical and subcortical chemical pathology in Alzheimer's disease as assessed by multislice proton magnetic resonance spectroscopic imaging Neurology 47 1996 696 704
44. A. van den Boogaart, A. Van Hecke, P. Van Huffel, S. Graveron-Demilly, D. van Ormondt, and R. de Beer MRUI: a graphical user interface for accurate routine MRS data analysis Proceedings of the ESMRMB 13th Annual Meeting, Prague 1996
45. P.G. Webb, N. Sailasuta, S.J. Kohler, T. Raidy, R.A. Moats, and R.E. Hurd Automated single-voxel proton MRS: technical development and multisite verification Magn. Reson. Med. 31 1994 365 373